Green Cures & Botanical Distribution Inc. begins countdown for the launching of Rico Suave
WINNETKA, Calif., Jan. 28, 2015 /PRNewswire/ — Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU) (“Green Cures”), a cannabis and industrial hemp products innovator, announced today that the countdown for the launching of Rico Suave energy drink/supplement has begun. The launch date of their highly anticipated product, which is infused with hemp & taurine has been scheduled for February 16, 2015.
Management of the company stated that on the date of launching, www.ricosuave.us will be accepting and processing orders from consumers across the country and around the globe. The site will also provide information about the convenience stores and grocery outlets throughout Los Angeles County, where Rico Suave can be purchased. These will include restaurants, night clubs, and food marts at gas stations such as, Mobile and Arco in selected cities. At the same time, www.ricosuave.us will feature promotional and marketing material for Rico Suave, including Rico Suave female models and promotional wear.
The company invites the public and the investment community to visit www.ricosuave.us today, and discover the energizing look of Rico Suave.
In closing, the company will provide additional updates as they become available.
About Green Cures & Botanical Distribution Inc.: Green Cures & Botanical Distribution Inc. is a development stage company that retails and wholesales hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc. operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc. is continuously creating and introducing products that promote a healthy life style.
FDA Statement: The statements contained in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Forward-looking statements are identified by wording such as “scheduled (future sense)”, “intend(s)”, “plan(s)”, “expect(s)”, “believe(s)”, “will”, “estimate(s)”, “anticipate(s)”, “expect(s)”, “may”, “would”, “could” or “should” or, in each case, the negative thereof, other variations thereon, or comparable terminology that implies anticipated future deliverables. The Company disclaims any obligation or intention to update any forward-looking statement for any reason.